Gyre Therapeutics Soars 12.28% Ahead of Earnings

Gyre Therapeutics' stock surged 12.28% in pre-market trading on May 7, 2025, marking a significant rise that has caught the attention of investors and analysts alike.

Gyre Therapeutics is expected to release its Q1 2025 earnings data before the market opens on Thursday, May 8th. This upcoming earnings report is likely to influence investor sentiment and could potentially drive further stock price movements.

The company has a market capitalization of $825.88 million, a PE ratio of 175.70 and a beta of 1.90. These financial metrics suggest that the stock is highly volatile and may be subject to significant price fluctuations in the near term.

Gyre Therapeutics has 579 employees, with a year-over-year change of -14 and a growth rate of -2.36%. The company generates $182,655 in revenue per employee and $20,872 in profits per employee, indicating strong financial performance on a per-employee basis.